반응식
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[S:9][C:10]3[CH:16]=[CH:15][CH:14]=[CH:13][C:11]=3[N:12]=2)=[CH:4][C:3]=1[Cl:17].[NH2:18][C@H:19]([C:25]([OH:27])=O)[CH2:20][CH2:21][CH2:22][CH2:23][NH2:24].N[C@H](C(O)=O)C>>[ClH:17].[ClH:17].[NH2:18][C@H:19]([C:25]([NH-:1])=[O:27])[CH2:20][CH2:21][CH2:22][CH2:23][NH2:24].[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[S:9][C:10]3[CH:16]=[CH:15][CH:14]=[CH:13][C:11]=3[N:12]=2)=[CH:4][C:3]=1[Cl:17]참가 물질
4
실험 절차
The title compound was prepared using the method of Example 22 but with 2-(4′-amino-3′-chlorophenyl)benzothiazole instead of 2-(4′-aminophenyl)-benzothiazole and BOC protected lysine instead of BOC protected alanine.
출처 및 근거
- ORD 기록
- ord-e365b54716bb493cbf42c13966c41724
- 출처 데이터셋
- uspto-grants-2005_02
- 특허 번호
- US06858633B1
연결된 노트
불러오는 중…